nivolumab,ipilimumab
ono Pharmaceuticals,BMS,natera
['colorectal', 'breast', 'rectal', 'natera', '$ntra ']
natera presents new colorectal and breast cancer data at esmo 2022, highlighting signatera's ability to inform treatment decisions in the adjuvant and neoadjuvant settings $ntra 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice